Vida Ventures GP III, L.L.C. 4
4 · Vigil Neuroscience, Inc. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Vida Ventures GP III, L.L.C.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2022-01-11−21,310→ 0 total(indirect: By Vida Ventures III-A, L.P.)→ Common Stock (7,684 underlying) - Purchase
Common Stock
2022-01-11$14.00/sh+3,852$53,928→ 11,536 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Common Stock
2022-01-11+7,684→ 7,684 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series B Preferred Stock
2022-01-11−9,243,756→ 0 total(indirect: By Vida Ventures III, L.P.)→ Common Stock (3,333,245 underlying) - Purchase
Common Stock
2022-01-11$14.00/sh+1,671,148$23,396,072→ 5,004,393 total(indirect: By Vida Ventures III, L.P.) - Conversion
Common Stock
2022-01-11+3,333,245→ 3,333,245 total(indirect: By Vida Ventures III, L.P.)
Footnotes (5)
- [F1]Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
- [F2]The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C.("Vida III GP") is the general partner of Vida III. Vida III GP disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
- [F3]The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A. Vida III GP disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
- [F4]On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
- [F5]On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.